Matthew Shair

NUVL

Matthew Shair serves as Director at Nuvalent, Inc. (NUVL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$6.99M

Net Position

Net Seller

$6.99M

Companies Traded

NUVL

Active Period

Feb 2025 – Nov 2025

3 total trades

Most Recent

Sell NUVL

Nov 24, 2025 · $820.3K

Matthew Shair's Insider Trading at Nuvalent, Inc. (NUVL)

Buys

0 · $0.00

Sells

3 · $6.99M

Total Shares Bought

Total Shares Sold

69,500

NUVL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Nov 24, 2025↗	Sell	7,500	$109.37	$820.3K
Oct 27, 2025↗	Sell	60,000	$100.26	$6.02M
Feb 24, 2025↗	Sell	2,000	$78.43	$156.9K

Related Insiders

James Richard Porter

director, officer: President and CEO

NUVLSell · Mar 6, 2026

Darlene Noci

officer: Chief Development Officer

NUVLSell · Feb 26, 2026

Deborah Ann Miller

officer: Chief Legal Officer

NUVLSell · Feb 26, 2026

Darlene Noci

Chief Development Officer

NUVLSell · Jan 29, 2026

Deborah Ann Miller

Chief Legal Officer

NUVLSell · Jan 22, 2026

Christopher Durant Turner

officer: Chief Medical Officer

NUVLSell · Jan 6, 2026

Alexandra Balcom

officer: Chief Financial Officer

NUVLSell · Jan 6, 2026

Henry E. Pelish

Chief Scientific Officer

NUVLSell · Jan 6, 2026

Explore More Insider Trading Data

NUVL Insider Trading Activity

View all insider trades at Nuvalent, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity